triethylenemelamine has been researched along with Bone Cancer in 1 studies
Triethylenemelamine: Toxic alkylating agent used in industry; also as antineoplastic and research tool to produce chromosome aberrations and cancers.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Judisch, GF | 1 |
| Apple, DJ | 1 |
| Fratkin, JD | 1 |
1 other study available for triethylenemelamine and Bone Cancer
| Article | Year |
|---|---|
Retinoblastoma. A survivor 12 years after treatment for metastatic disease.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Child, Preschool; Eye Neoplasms; Follow-Up Studies; Humans | 1980 |